Adult stem cell research has produced some dividends, but since many researchers still think embryonic cells offer far more potential, why continue to shackle and shortchange U.S. researchers?
Office of Strategic Communication
Adult stem cell research has produced some dividends, but since many researchers still think embryonic cells offer far more potential, why continue to shackle and shortchange U.S. researchers?